Unnamed monoclonal antibody therapy

· Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Unnamed monoclonal antibody therapy, covering 2007-12-28 to 2007-12-28. Get the full timeline:

Most recent: Clinical Trial Update: Monoclonal Antibody Treatment for Non-Hodgkin's Lymphoma (Low-Grade) [Phase 2]